Have a feature idea you'd love to see implemented?
Let us know!
TWST Twist Bioscience Corp
Price (delayed)
$41.66
Market cap
$2.47B
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$3.6
Enterprise value
$2.33B
Twist Bioscience is a leading and rapidly growing synthetic biology and genomics company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The core of
Highlights
TWST's gross profit is up by 49% year-on-year and by 11% since the previous quarter
TWST's revenue is up by 28% YoY and by 6% from the previous quarter
The net income rose by 5% QoQ but it fell by 2% YoY
Twist Bioscience's equity has decreased by 24% YoY and by 3.8% QoQ
TWST's quick ratio is down by 16% year-on-year
Key stats
What are the main financial stats of TWST
Market
Valuations
Earnings
Shares outstanding
59.36M
Market cap
$2.47B
Enterprise value
$2.33B
Price to earnings (P/E)
N/A
Price to book (P/B)
5.16
Price to sales (P/S)
7.72
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
7.45
Revenue
$312.97M
EBIT
-$208.14M
EBITDA
-$175.77M
Free cash flow
-$69.17M
Per share
Balance sheet
Liquidity
EPS
-$3.6
Free cash flow per share
-$1.19
Book value per share
$8.07
Revenue per share
$5.39
TBVPS
$8.86
Total assets
$614.32M
Total liabilities
$141.63M
Debt
$85.03M
Equity
$472.69M
Working capital
$275.77M
Debt to equity
0.18
Current ratio
4.88
Quick ratio
4.38
Net debt/EBITDA
0.8
Margins
Efficiency
Dividend
EBITDA margin
-56.2%
Gross margin
42.6%
Net margin
-66.7%
Operating margin
-70.6%
Return on assets
-31.1%
Return on equity
-39.5%
Return on invested capital
-63.5%
Return on capital employed
-38.3%
Return on sales
-66.5%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
TWST stock price
How has the Twist Bioscience stock price performed over time
Intraday
1.34%
1 week
6.93%
1 month
-8.14%
1 year
75.71%
YTD
13.02%
QTD
-7.79%
Financial performance
How have Twist Bioscience's revenue and profit performed over time
Revenue
$312.97M
Gross profit
$133.35M
Operating income
-$220.83M
Net income
-$208.73M
Gross margin
42.6%
Net margin
-66.7%
TWST's gross profit is up by 49% year-on-year and by 11% since the previous quarter
TWST's revenue is up by 28% YoY and by 6% from the previous quarter
Twist Bioscience's net margin has increased by 20% YoY and by 11% from the previous quarter
Twist Bioscience's operating margin has increased by 20% YoY and by 11% QoQ
Growth
What is Twist Bioscience's growth rate over time
Valuation
What is Twist Bioscience stock price valuation
P/E
N/A
P/B
5.16
P/S
7.72
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
7.45
TWST's EPS is up by 6% since the previous quarter
Twist Bioscience's equity has decreased by 24% YoY and by 3.8% QoQ
TWST's P/B is 12% above its last 4 quarters average of 4.6 but 2.6% below its 5-year quarterly average of 5.3
TWST's P/S is 63% below its 5-year quarterly average of 20.6 and 7% below its last 4 quarters average of 8.3
TWST's revenue is up by 28% YoY and by 6% from the previous quarter
Efficiency
How efficient is Twist Bioscience business performance
The return on equity has declined by 32% year-on-year
The ROA has decreased by 27% YoY
Twist Bioscience's ROIC has decreased by 27% YoY
TWST's return on sales is up by 20% year-on-year and by 11% since the previous quarter
Dividends
What is TWST's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for TWST.
Financial health
How did Twist Bioscience financials performed over time
Twist Bioscience's total assets has decreased by 21% YoY and by 3.7% QoQ
The current ratio has contracted by 16% YoY
Twist Bioscience's debt is 82% less than its equity
Twist Bioscience's equity has decreased by 24% YoY and by 3.8% QoQ
Twist Bioscience's debt to equity has increased by 20% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.